GL1X · GenesisL1 explorer

MolNFT v1 · #34028 · protein

Crystal structure of 2-deoxy-scyllo-inosose synthase

2D2X: “Crystal structure of 2-deoxy-scyllo-inosose synthase”. X-ray diffraction, 2 ligands (CO, SO3), 4 pockets (best druggability 0.75). MolNFT v1 #34028 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2D2X
Type
protein
Length
705 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2-deoxy-scyllo-inosose synthase
EC
4.2.3.-
UniProt
Q9S5E2
Ligands
CO, SO3
Pockets
4 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2-deoxy-scyllo-inosose synthase (EC 4.2.3.-)protein35346% helix, 22% strandQ9S5E2
B2-deoxy-scyllo-inosose synthase (EC 4.2.3.-)protein35245% helix, 22% strandQ9S5E2

Ligands and binding sites

  • CO · Cobalt (II) ion · metal · 4 copies · chains A, B
  • SO3 · Sulfite ion · ion · 2 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110600.750.7776GOL
210070.730.7773CO, GOL
34420.630.7646empty
4720.380.7819empty

Interfaces

1 interface between chains.

  • A–B · 1100 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 2D2X · Crystal structure of 2-deoxy-scyllo-inosose synthase · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9S5E2 · AlphaFold monomer V2.0 prediction for 2-deoxy-scyllo-inosose synthase (Q9S5E2) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.